Phase 2 trial of avelumab in combination with gemcitabine in advanced leiomyosarcoma as a second-line treatment (EAGLES, Korean Cancer Study Group UN18-09)
- Miso Kim
- , Yu Jung Kim
- , Koung Jin Suh
- , Se Hyun Kim
- , Jeong Eun Kim
- , Juhyeon Jeong
- , Jung Yong Hong
- , Jeeyun Lee
- , Su Jin Lee
- , Sung Yong Oh
- , Jung Hoon Kim
- , Gyeong Won Lee
- , Mi Sun Ahn
- , Wonyoung Choi
- , Yoon Ji Choi
- , Taebum Lee
- , Chiyoon Oum
- , Jeongkyu Kim
- , Young Saing Kim*
- , Jin Hee Ahn*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
4
Link opens in a new tab
Citations
(Scopus)